PL2026828T3 - Zastosowanie co najmniej jednego polifenolu do wspomagania zdrowia oczu - Google Patents

Zastosowanie co najmniej jednego polifenolu do wspomagania zdrowia oczu

Info

Publication number
PL2026828T3
PL2026828T3 PL07766688T PL07766688T PL2026828T3 PL 2026828 T3 PL2026828 T3 PL 2026828T3 PL 07766688 T PL07766688 T PL 07766688T PL 07766688 T PL07766688 T PL 07766688T PL 2026828 T3 PL2026828 T3 PL 2026828T3
Authority
PL
Poland
Prior art keywords
polyphenol
eye health
promoting eye
promoting
health
Prior art date
Application number
PL07766688T
Other languages
English (en)
Inventor
Jin Zhang
Michael Griffin Hayek
Original Assignee
Iams Europe B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Europe B V filed Critical Iams Europe B V
Publication of PL2026828T3 publication Critical patent/PL2026828T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/742—Coffea, e.g. coffee
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
PL07766688T 2006-06-08 2007-06-07 Zastosowanie co najmniej jednego polifenolu do wspomagania zdrowia oczu PL2026828T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81185706P 2006-06-08 2006-06-08
EP07766688.1A EP2026828B1 (en) 2006-06-08 2007-06-07 Use of at least one polyphenol for promoting eye health
PCT/IB2007/052165 WO2007141764A1 (en) 2006-06-08 2007-06-07 Use of at least one polyphenol for promoting eye health

Publications (1)

Publication Number Publication Date
PL2026828T3 true PL2026828T3 (pl) 2015-11-30

Family

ID=38473953

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07766688T PL2026828T3 (pl) 2006-06-08 2007-06-07 Zastosowanie co najmniej jednego polifenolu do wspomagania zdrowia oczu

Country Status (9)

Country Link
US (4) US8012513B2 (pl)
EP (1) EP2026828B1 (pl)
JP (2) JP2009538900A (pl)
AU (1) AU2007257523B2 (pl)
CA (1) CA2654303C (pl)
ES (1) ES2541911T3 (pl)
HU (1) HUE025064T2 (pl)
PL (1) PL2026828T3 (pl)
WO (1) WO2007141764A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070286925A1 (en) * 2006-06-08 2007-12-13 The Procter & Gamble Company Composition for improving eye health
US8012513B2 (en) 2006-06-08 2011-09-06 The Procter & Gamble Company Method for promoting eye health
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
EP2090178A1 (en) * 2008-02-13 2009-08-19 Bühler AG Pet food product and method for its manufacture
CA2785997A1 (en) * 2010-01-06 2011-07-14 Nestec S.A. Dietary regimens useful for mimicking caloric restriction
ES2374482B1 (es) * 2010-08-05 2012-12-27 Universidad Autónoma de Madrid Composición para la reducción de síntomas asociados a la menopausia.
US20120121721A1 (en) * 2010-11-16 2012-05-17 Michael James Skin care products and compositions
WO2012097018A1 (en) 2011-01-14 2012-07-19 The Iams Company Compositions and methods relating to carotenoids
US20140113814A1 (en) * 2012-10-18 2014-04-24 Plant Activity Ltd. Tea extracts and uses in promoting plant growth
US20160066608A1 (en) * 2014-09-04 2016-03-10 Jeffery M. Meyer Potato salad mix
JP2016185939A (ja) * 2015-03-27 2016-10-27 ロート製薬株式会社 経口組成物
BR112018008453A2 (pt) * 2015-10-27 2018-11-06 Activinside composição antioxidante sinergicamente eficaz para animais de estimação
CN109198349A (zh) * 2017-07-03 2019-01-15 北京神飞航天应用技术研究院 一种能提高航天员视力的药食同源固体饮料
CN110996920A (zh) 2017-07-26 2020-04-10 太杰先软嚼有限责任公司 用于兽医应用的无淀粉软咀嚼物
CN107997133A (zh) * 2017-11-20 2018-05-08 广州市澳万生物科技有限公司 基于CRHD的明目护眼的β胡萝卜素口服液及其制备方法
CN112367848A (zh) * 2018-06-14 2021-02-12 马斯公司 用于支持患有癌症的动物的组合物
CN109619257A (zh) * 2019-01-23 2019-04-16 广州富诺健康科技股份有限公司 一种护眼软糖及其制备方法
KR102471694B1 (ko) * 2019-12-12 2022-11-29 주식회사 팜스킨 강황 추출물을 함유하는 블루라이트 차단용 조성물
FR3105790B1 (fr) * 2019-12-26 2022-01-14 Biophytis Composés chimiques ciblant l’œil et leur utilisation dans le traitement de maladies oculaires
US11219661B2 (en) 2020-01-20 2022-01-11 Paul Campbell Ulcerative colitis medication
JP7005043B2 (ja) * 2020-07-08 2022-02-10 株式会社東洋新薬 網膜保護組成物
JP7809717B2 (ja) * 2021-03-17 2026-02-02 ユ,ヒョギョン コエンザイムq10含有液状補助飼料組成物
MX2021009520A (es) * 2021-08-06 2023-02-07 Foodvica S A De C V Composicion oftalmica para el tratamiento de trastornos visuales.
JP2023108632A (ja) * 2022-01-26 2023-08-07 大道 藤本 ドッグフード
JP7559010B2 (ja) * 2022-06-28 2024-10-01 アニコム ホールディングス株式会社 フード提案システム及びフード提案方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0610132B2 (ja) * 1985-11-27 1994-02-09 千寿製薬株式会社 糖尿病性白内障治療薬
AU673700B2 (en) 1993-01-27 1996-11-21 Scotia Holdings Plc Triglycerides
US6329432B2 (en) 1993-06-28 2001-12-11 The Howard Foundation Mesozeaxanthin formulations for treatment of retinal disorders
US5591773A (en) 1994-03-14 1997-01-07 The Trustees Of Columbia University In The City Of New York Inhibition of cataract formation, diseases resulting from oxidative stress, and HIV replication by caffeic acid esters
WO1997048388A1 (en) 1996-06-17 1997-12-24 The Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
US6080788A (en) 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US20020006447A1 (en) * 1998-04-21 2002-01-17 Mitsui Norin Co., Ltd. Anti-chlamydia agent
IT1299197B1 (it) * 1998-06-30 2000-02-29 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio.
US5955102A (en) 1998-09-04 1999-09-21 Amway Corporation Softgel capsule containing DHA and antioxidants
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
WO2000062812A1 (en) 1999-04-20 2000-10-26 Advocare International Llc Nutritional composition for improved cognitive performance
KR20020016833A (ko) 1999-06-15 2002-03-06 뉴트리-로직스, 인크. 발병 감소에 유용한 영양 제제, 관련 치료 방법 및 성분스크리닝 방법
US6340705B1 (en) 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
EP1250052A1 (en) * 2000-01-25 2002-10-23 Juvenon, Inc. Nutritional supplements for aged pets
JP2001270832A (ja) * 2000-03-27 2001-10-02 Ito En Ltd 網膜障害予防剤
US6254898B1 (en) 2000-05-25 2001-07-03 Protective Factors, Inc. Nutraceutical composition for protection against solar radiation
GB0016452D0 (en) 2000-07-04 2000-08-23 Kilgowan Limited Vitamin K and essential fatty acids
WO2002020028A2 (en) 2000-09-06 2002-03-14 Braswell A Glenn Method and composition for enhancing vision
US20020076469A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US20040220118A1 (en) 2001-02-02 2004-11-04 Bland Jeffrey S. Medical composition for balancing bodily processes
KR20020071152A (ko) * 2001-03-05 2002-09-12 정풍한방제약주식회사 기능성 식품 조성물 및 그 제조방법
US6660297B2 (en) * 2001-03-23 2003-12-09 Bausch & Lomb Incorporated Nutritional supplement to treat macular degeneration
AU2002309931A1 (en) 2001-05-17 2002-11-25 Pilot Therapeutics, Inc. Method for enriching tissues in long chain polyunsaturated fatty acids
AU784852B2 (en) 2001-08-10 2006-07-06 Mars, Incorporated Canine support diet
JP2003064360A (ja) * 2001-08-28 2003-03-05 Nissui Pharm Co Ltd 抗酸化剤
US20040076691A1 (en) * 2002-01-16 2004-04-22 David Haines Anti-inflammatory formulations
GB0202258D0 (en) 2002-01-31 2002-03-20 Dodson & Horrell Ltd Annimal feed supplement
AU2002353487A1 (en) * 2002-03-27 2003-10-08 All India Institute Of Medical Sciences Herbal ophthalmic formulation for preventing cataract
CA2519028A1 (en) * 2002-04-03 2003-10-16 Maureen A. Mckenzie Vaccinium species compositions with novel beneficial properties
JP2003319750A (ja) * 2002-05-07 2003-11-11 Nisshin Pet Food Kk ペットフード
US6649195B1 (en) 2002-07-11 2003-11-18 Vitacost.Com, Inc. Eyesight enhanced maintenance composition
US6974841B1 (en) 2002-09-27 2005-12-13 Rapisarda Family Irrevocable Trust Pet anti-aging wellness supplement
US20060251750A1 (en) * 2002-09-30 2006-11-09 Tabor Aaron T Soy formulations and their use in skin care
CN100401917C (zh) * 2003-02-17 2008-07-16 深圳市海川实业股份有限公司 一种葡萄色香油及其生产工艺
JP2007524402A (ja) 2003-07-03 2007-08-30 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法
ITMI20031396A1 (it) 2003-07-09 2005-01-10 Giuliani Spa Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
JP2005065525A (ja) * 2003-08-20 2005-03-17 Koyo Shokai:Kk ルテインおよびブルーベリー含有飲料
WO2005027950A1 (en) 2003-09-12 2005-03-31 Ray And Terry's Health Products, Inc. Eye nutritional supplement
WO2005032478A2 (en) 2003-10-01 2005-04-14 Yasoo Health, Inc. Treatment for diabetic microvascular and macrovascular complications
US7070816B2 (en) * 2003-12-05 2006-07-04 New Chapter, Inc. Methods for treating prostatic intraepithelial neoplasia with herbal compositions
US7267830B2 (en) 2003-12-19 2007-09-11 Alcon, Inc. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
MY142017A (en) * 2004-03-19 2010-08-16 Nestec Sa Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
EP1755406B1 (en) * 2004-04-16 2012-09-26 Nestec S.A. Compositions for reducing oxidative stress in an animal
EP1588711A1 (en) * 2004-04-21 2005-10-26 AOL Corporation Composition trapping radicals in organism
US20050266051A1 (en) 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
US8168161B2 (en) 2004-12-22 2012-05-01 Hill's Pet Nutrition, Inc. Method to promote oral health in companion animals
US20070286925A1 (en) 2006-06-08 2007-12-13 The Procter & Gamble Company Composition for improving eye health
US8012513B2 (en) 2006-06-08 2011-09-06 The Procter & Gamble Company Method for promoting eye health

Also Published As

Publication number Publication date
CA2654303A1 (en) 2007-12-13
US8389028B2 (en) 2013-03-05
HUE025064T2 (en) 2016-01-28
EP2026828A1 (en) 2009-02-25
US8691296B2 (en) 2014-04-08
US20130142768A1 (en) 2013-06-06
ES2541911T3 (es) 2015-07-28
WO2007141764A1 (en) 2007-12-13
US20140161913A1 (en) 2014-06-12
US8012513B2 (en) 2011-09-06
JP2013078318A (ja) 2013-05-02
JP2009538900A (ja) 2009-11-12
AU2007257523A1 (en) 2007-12-13
AU2007257523B2 (en) 2013-04-11
US20110274782A1 (en) 2011-11-10
US20070286912A1 (en) 2007-12-13
CA2654303C (en) 2016-07-26
EP2026828B1 (en) 2015-04-15

Similar Documents

Publication Publication Date Title
GB0720762D0 (en) Assembly for orthopaedic surgery
EP2092915A4 (en) CORNEA OPERATION UNIT
IL198381A0 (en) Gas-enriched fluid compositions for eye treatment
IL194113A (en) Combinations of stroke treatment materials
IL230335A (en) A drug used to treat cartilage disease
PL2154969T3 (pl) Leczenie synukleinopatii
SI2415763T1 (sl) Farmacevtski sestavek za zdravljenje ali preprečevanje glavkoma
IL190779A0 (en) Compositions for treatment of eye diseases
AU320817S (en) Surgical reamer
ZA201100697B (en) Orthopedic prosthesis
PL2209458T3 (pl) Kompozycje do traktowania skóry
GB0909297D0 (en) Composition for the treatment of skin conditions
EP2060264A4 (en) AGENT FOR TREATING OCULAR DISEASES
GB0600692D0 (en) Well treatment
IL208396A0 (en) Guided surgery
GB0808509D0 (en) Ophthalmic surgical apparatus
EP2174956A4 (en) COMPOSITIONS FOR ANTIFIBRINOLYSIS THERAPY
IL201119A0 (en) Methods and compositions of derivatives of probucol for the treatment of diabetes
GB0723100D0 (en) Treatment of HFnEF
GB0804968D0 (en) Composition for bone health maintenance
GB0607952D0 (en) Novel treatment
GB0604782D0 (en) Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders
GB0623740D0 (en) Treatment of disease
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
GB0700578D0 (en) Composition for treating blood conditions